BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 3, 2024
See today's BioWorld
Home
» Other news to note for May 4, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for May 4, 2021
May 4, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Abpro, Alligator, Aphios, APR, Aria, Astrazeneca, Aura, Bioarctic, Biocartis, Cartesian, CSL, Edgewise, Effector, Enesi, Esteve, Evotec, Exelixis, Gain, Gamamabs, Gemini, Gensight, Hcmed, Hoth, Hutchmed, Immunicum, J&J, Kowa, Lilly, Logicbio, Moderna, Moonlake, Merck KGaA, Nflection, Novobiome, Ocugen, Plus, Proqr, Recce, Relief, Samsung Bioepis, Sesen, Stoke, Twoxar, Xoma, Yarrow.
BioWorld
Briefs
Other news to note
Coronavirus